TY - JOUR
KW - Buprenorphine/therapeutic use
KW - Certification
KW - Humans
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - Physicians
KW - buprenorphine X-waiver
KW - opioid use disorder
KW - Perinatal addiction
AU - E. M. Cleary
AU - M. C. Smid
AU - J. E. Charles
AU - K. M. Jones
AU - M. M. Costantine
AU - G. Saade
AU - K. M. Rood
A1 - 
AD - Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH. Electronic address: ErinClearyMD@gmail.com.; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, UT.; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, UT.; College of Nursing, University of Utah Health, Salt Lake City, UT.; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH.; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX.; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH.
BT - American journal of obstetrics & gynecology MFM
C5 - Education & Workforce; Healthcare Disparities; Healthcare Policy; Opioids & Substance Use
CP - 6
CY - United States
DO - 10.1016/j.ajogmf.2021.100451
IS - 6
JF - American journal of obstetrics & gynecology MFM
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2021
SN - 2589-9333; 2589-9333
SP - 100451
T1 - Buprenorphine X-waiver exemption - beyond the basics for the obstetrical provider
T2 - American journal of obstetrics & gynecology MFM
TI - Buprenorphine X-waiver exemption - beyond the basics for the obstetrical provider
U1 - Education & Workforce; Healthcare Disparities; Healthcare Policy; Opioids & Substance Use
U2 - 34320429
U3 - 10.1016/j.ajogmf.2021.100451
VL - 3
VO - 2589-9333; 2589-9333
Y1 - 2021
Y2 - Nov
ER -